Cargando…

Ursodeoxycholic acid augmentation in treatment-refractory schizophrenia: a case report

BACKGROUND: Treatment-resistance is recognized as a significant dilemma in schizophrenia, which has been reported to involve approximately one-third of patients with schizophrenia. CASE PRESENTATION: This case report described a 12-week treatment course for a 39-year-old Persian man with treatment-r...

Descripción completa

Detalles Bibliográficos
Autor principal:	Khosravi, Mohsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460790/ https://www.ncbi.nlm.nih.gov/pubmed/32867840 http://dx.doi.org/10.1186/s13256-020-02484-9

Ejemplares similares

Ursodeoxycholic Acid in Patients With Treatment-Resistant Schizophrenia Suffering From Coronavirus Disease 2019: A Hypothesis Letter
por: Khosravi, Mohsen
Publicado: (2021)

Ursodeoxycholic acid and bezafibrate were useful for steroid-refractory, immune-related hepatitis: a case report
por: Onishi, Sachiyo, et al.
Publicado: (2020)

Lewy body dementia: Ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction
por: Khosravi, Mohsen
Publicado: (2021)

Efficacy of Chenodeoxycholic Acid and Ursodeoxycholic Acid Treatments for Refractory Functional Dyspepsia
por: Jang, Sung Ill, et al.
Publicado: (2022)

Successful treatment of an infant with congenital bile acid synthesis disorder type 3 by ursodeoxycholic acid: a case report
por: Mo, Weiqian, et al.
Publicado: (2022)

Case Report: Ursodeoxycholic acid treatment in Niemann-Pick disease type C; clinical experience in four cases
por: Evans, William R.H., et al.
Publicado: (2017)

Pimozide Augmentation of Clozapine in Hebephrenic Schizophrenia: A Case Report
por: Mendhekar, D.N., et al.
Publicado: (2003)

Levothyroxine Augmentation in Clozapine Resistant Schizophrenia: A Case Report and Review
por: Seddigh, Ruohollah, et al.
Publicado: (2015)

Treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report
por: Khosravi, Mohsen
Publicado: (2020)

Biological synthesis of ursodeoxycholic acid
por: Song, Peng, et al.
Publicado: (2023)

Augmentation of Antipsychotic Medications with Low-Dose Clozapine in Treatment-Resistant Schizophrenia—Case Reports and Discussion
por: Harrison, Zoe, et al.
Publicado: (2021)

Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reports
por: Ito, Tomoki, et al.
Publicado: (2014)

Ursodeoxycholic Acid Triggers Primary Enterolith Growth in a Crohn's Disease Patient with Jejunal Stenosis
por: Matsui, Hiroki, et al.
Publicado: (2021)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012)

The Conservative Management of Choledocholithiasis With Ursodeoxycholic Acid
por: Oluboyede, Daniel O, et al.
Publicado: (2023)

Treatment of refractory catatonic schizophrenia with low dose aripiprazole
por: Sasaki, Tsuyoshi, et al.
Publicado: (2012)

Ursodeoxycholic acid treatment in a rat model of cancer cachexia
por: Tschirner, Anika, et al.
Publicado: (2011)

Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
por: Kotb, Magd A.
Publicado: (2012)

A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report
por: Qiao, Fei, et al.
Publicado: (2023)

Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation for patients with treatment-refractory bipolar depression: a case report
por: Adida, Marc, et al.
Publicado: (2014)

Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients
por: Colapietro, Francesca, et al.
Publicado: (2023)

Ursodeoxycholic acid production by Gibberella zeae mutants
por: Kollerov, Vyacheslav, et al.
Publicado: (2022)

Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review
por: Li, Xuan, et al.
Publicado: (2020)

Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report
por: Gahr, Maximilian, et al.
Publicado: (2012)

Predictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis
por: Shu, Yanyun, et al.
Publicado: (2021)

Fibrinogen storage disease in a Chinese boy with de novo fibrinogen Aguadilla mutation: Incomplete response to carbamazepine and ursodeoxycholic acid
por: Zhang, Mei-Hong, et al.
Publicado: (2016)

Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report
por: Ram, Dushad, et al.
Publicado: (2015)

Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review
por: Reardon, Jillian, et al.
Publicado: (2016)

Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis
por: Zhang, Yang, et al.
Publicado: (2016)

REFRACTORY SCHIZOPHRENIA, CLOZAPINE AND EPILEPSY : MANAGEMENT STRATEGIES
por: Guha, Prathama, et al.
Publicado: (1998)

Incretin secretion stimulated by ursodeoxycholic acid in healthy subjects
por: Murakami, Masanori, et al.
Publicado: (2013)

Ursodeoxycholic Acid at 18–22 mg/kg/d Showed a Promising Capacity for Treating Refractory Primary Biliary Cholangitis
por: Xiang, Xinyu, et al.
Publicado: (2021)

Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid
por: Joutsiniemi, Titta, et al.
Publicado: (2015)

Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study
por: Cançado, Guilherme Grossi Lopes, et al.
Publicado: (2022)

Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial
por: Barnes, Thomas R.E., et al.
Publicado: (2018)

Fecal microbiota transplantation augmented by a sulfide‐reducing diet for refractory ulcerative colitis: A case report with functional metagenomic analysis
por: Bryant, Robert V, et al.
Publicado: (2021)

Plasmapheresis in the Treatment of Refractory Myoclonic Status. A Case Report
por: Gutierrez-Gutierrez, Judit, et al.
Publicado: (2021)

Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study
por: Strzelecki, Dominik, et al.
Publicado: (2015)

Treatment-refractory schizophrenia
por: Caspi, Asaf, et al.
Publicado: (2004)

G-CSF mediated neutrophil augmentation in a unique case of comorbid idiopathic Parkinson’s disease and treatment-resistant schizophrenia on clozapine
por: Morrow, Olivia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rorefqss4umbt3381gc9o4lliv